---
figid: PMC12027666__ijms-26-03716-g002
figtitle: S1P-mediated signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12027666
filename: ijms-26-03716-g002.jpg
figlink: /pmc/articles/PMC12027666/figure/F2/
number: F2
caption: S1P-mediated signaling pathways. Schematic illustration showing intracellular
  S1P can be transported via ABC/SPNS2 transporters and bind S1PR1-S1PR5 G-protein
  coupled receptors and activate several pro-tumorigenic pathways that lead to cellular
  proliferation, growth and migration. Gi/o activates pro-survival pathways PI3K/Akt
  or Ras/MAPK/ERK, which leads to increased cell proliferation and growth of the cancer
  cells, making existing apoptosis-inducing treatment inefficient [31]. S1P can upregulate
  the production of P-glycoprotein, which actively extrudes cancer-targeted drugs
  out of the cell, thereby enhancing tumor drug resistance [29]. SPHK activates the
  JAK/STAT signaling pathway via the S1PR1 receptor in colon cancer cell lines, which
  induces migration and invasiveness [32]
papertitle: 'Drug Resistance: The Role of Sphingolipid Metabolism'
reftext: Assem Zhakupova, et al. Int J Mol Sci. 2025 Apr;26(8).
year: '2025'
doi: 10.3390/ijms26083716
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: sphingolipid metabolism | drug resistance | glucosylceramide synthase |
  sphingosine kinase | acid ceramidase | sphingosine-1-phosphate | sphingomyelinase
automl_pathway: 0.9158831
figid_alias: PMC12027666__F2
figtype: Figure
redirect_from: /figures/PMC12027666__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12027666__ijms-26-03716-g002.html
  '@type': Dataset
  description: S1P-mediated signaling pathways. Schematic illustration showing intracellular
    S1P can be transported via ABC/SPNS2 transporters and bind S1PR1-S1PR5 G-protein
    coupled receptors and activate several pro-tumorigenic pathways that lead to cellular
    proliferation, growth and migration. Gi/o activates pro-survival pathways PI3K/Akt
    or Ras/MAPK/ERK, which leads to increased cell proliferation and growth of the
    cancer cells, making existing apoptosis-inducing treatment inefficient [31]. S1P
    can upregulate the production of P-glycoprotein, which actively extrudes cancer-targeted
    drugs out of the cell, thereby enhancing tumor drug resistance [29]. SPHK activates
    the JAK/STAT signaling pathway via the S1PR1 receptor in colon cancer cell lines,
    which induces migration and invasiveness [32]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ABCB6
  - SPNS2
  - S1PR1
  - S1PR2
  - SRC
  - FGR
  - FYN
  - YES1
  - SPHK1
  - STAT3
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - WASF1
  - MTOR
  - RPTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - S1PR4
  - S1PR5
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - ATF6B
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - ROCK1
  - ROCK2
  - MAPK8
  - MAPK9
  - phosphate
  - CAMP
  - Ras
  - Sphingosine
  - MEK
---
